Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine.

Tchilian E, Holzer B.

Viruses. 2017 May 5;9(5). pii: E98. doi: 10.3390/v9050098. Review.

2.

Development of an Alternative Modified Live Influenza B Virus Vaccine.

Santos JJS, Finch C, Sutton T, Obadan A, Aguirre I, Wan Z, Lopez D, Geiger G, Gonzalez-Reiche AS, Ferreri L, Perez DR.

J Virol. 2017 May 26;91(12). pii: e00056-17. doi: 10.1128/JVI.00056-17. Print 2017 Jun 15.

3.

Spliceosome SNRNP200 Promotes Viral RNA Sensing and IRF3 Activation of Antiviral Response.

Tremblay N, Baril M, Chatel-Chaix L, Es-Saad S, Park AY, Koenekoop RK, Lamarre D.

PLoS Pathog. 2016 Jul 25;12(7):e1005772. doi: 10.1371/journal.ppat.1005772. eCollection 2016 Jul. Erratum in: PLoS Pathog. 2017 Jan 24;13(1):e1006174.

4.

The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.

Abente EJ, Santos J, Lewis NS, Gauger PC, Stratton J, Skepner E, Anderson TK, Rajao DS, Perez DR, Vincent AL.

J Virol. 2016 Aug 26;90(18):8266-80. doi: 10.1128/JVI.01002-16. Print 2016 Sep 15.

5.

Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.

Morgan SB, Hemmink JD, Porter E, Harley R, Shelton H, Aramouni M, Everett HE, Brookes SM, Bailey M, Townsend AM, Charleston B, Tchilian E.

J Immunol. 2016 Jun 15;196(12):5014-23. doi: 10.4049/jimmunol.1502632. Epub 2016 May 6.

6.

Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.

Souza CK, Rajão DS, Loving CL, Gauger PC, Pérez DR, Vincent AL.

Clin Vaccine Immunol. 2016 Jun 6;23(6):470-82. doi: 10.1128/CVI.00563-15. Print 2016 Jun.

7.

Codon Deletions in the Influenza A Virus PA Gene Generate Temperature-Sensitive Viruses.

Meyer L, Sausset A, Sedano L, Da Costa B, Le Goffic R, Delmas B.

J Virol. 2016 Jan 20;90(7):3684-93. doi: 10.1128/JVI.03101-15.

8.

Optimal Use of Vaccines for Control of Influenza A Virus in Swine.

Sandbulte MR, Spickler AR, Zaabel PK, Roth JA.

Vaccines (Basel). 2015 Jan 30;3(1):22-73. doi: 10.3390/vaccines3010022. Review.

9.

Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.

Hughes HR, Vincent AL, Brockmeier SL, Gauger PC, Pena L, Santos J, Braucher DR, Perez DR, Loving CL.

Clin Vaccine Immunol. 2015 Oct;22(10):1109-20. doi: 10.1128/CVI.00358-15. Epub 2015 Aug 19.

10.

Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation.

Da Costa B, Sausset A, Munier S, Ghounaris A, Naffakh N, Le Goffic R, Delmas B.

J Virol. 2015 Jun;89(12):6376-90. doi: 10.1128/JVI.00589-15. Epub 2015 Apr 8.

11.

Reverse zoonosis of influenza to swine: new perspectives on the human-animal interface.

Nelson MI, Vincent AL.

Trends Microbiol. 2015 Mar;23(3):142-53. doi: 10.1016/j.tim.2014.12.002. Epub 2015 Jan 4. Review.

12.

All-in-one bacmids: an efficient reverse genetics strategy for influenza A virus vaccines.

Chen H, Angel M, Li W, Finch C, Gonzalez AS, Sutton T, Santos J, Perez DR.

J Virol. 2014 Sep 1;88(17):10013-25. doi: 10.1128/JVI.01468-14. Epub 2014 Jun 18.

13.

Roles of major histocompatibility complex class II in inducing protective immune responses to influenza vaccination.

O E, Lee YT, Ko EJ, Kim KH, Lee YN, Song JM, Kwon YM, Kim MC, Perez DR, Kang SM.

J Virol. 2014 Jul;88(14):7764-75. doi: 10.1128/JVI.00748-14. Epub 2014 Apr 23.

14.

Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.

Loving CL, Lager KM, Vincent AL, Brockmeier SL, Gauger PC, Anderson TK, Kitikoon P, Perez DR, Kehrli ME Jr.

J Virol. 2013 Sep;87(17):9895-903. doi: 10.1128/JVI.01038-13. Epub 2013 Jul 3.

15.

Influenza viruses with rearranged genomes as live-attenuated vaccines.

Pena L, Sutton T, Chockalingam A, Kumar S, Angel M, Shao H, Chen H, Li W, Perez DR.

J Virol. 2013 May;87(9):5118-27. doi: 10.1128/JVI.02490-12. Epub 2013 Feb 28.

16.

Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.

Zheng D, Yi Y, Chen Z.

Viruses. 2012 Dec 10;4(12):3589-605. doi: 10.3390/v4123589. Review.

17.

Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs.

Loving CL, Vincent AL, Pena L, Perez DR.

Vaccine. 2012 Aug 31;30(40):5830-8. doi: 10.1016/j.vaccine.2012.07.033. Epub 2012 Jul 24.

18.

Strain-dependent effects of PB1-F2 of triple-reassortant H3N2 influenza viruses in swine.

Pena L, Vincent AL, Loving CL, Henningson JN, Lager KM, Li W, Perez DR.

J Gen Virol. 2012 Oct;93(Pt 10):2204-14. doi: 10.1099/vir.0.045005-0. Epub 2012 Jul 18.

19.

Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease.

Vincent AL, Ma W, Lager KM, Richt JA, Janke BH, Sandbulte MR, Gauger PC, Loving CL, Webby RJ, García-Sastre A.

J Virol. 2012 Oct;86(19):10597-605. doi: 10.1128/JVI.01439-12. Epub 2012 Jul 18.

20.

Microneedle and mucosal delivery of influenza vaccines.

Kang SM, Song JM, Kim YC.

Expert Rev Vaccines. 2012 May;11(5):547-60. doi: 10.1586/erv.12.25. Review.

Supplemental Content

Support Center